Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...

Novo Nordisk (NYSE: NVO) shareholders know all about the ups and downs of pharmaceutical stock investing. From the beginning ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.

March 4, 2025 South African watchdog probes Novo Nordisk and Sanofi over insulin South Africa's competition ... its experimental anti-obesity and type 2 diabetes drug in the next four to five ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and ...

March 4 (Reuters) - South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority ...

Novo Nordisk (NYSE: NVO ... receptors with Ozempic nudges your pancreas to secrete more insulin, making it a perfect fit for many type 2 diabetes patients. It also acts on receptors in the ...